Showing results (1-10 of 18) with videos related to
Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|July 4, 2013
Amplification and sequencing of the hepatitis C virus NS3/4A protease and the NS5B polymerase regions for genotypic resistance detection of clinical isolates of subtypes 1a and 1bDiana Koletzki, Theresa Pattery, Bart Fevery, et al.Antimicrobial Agents and Chemotherapy|September 23, 2015
In Vitro Activity of Simeprevir against Hepatitis C Virus Genotype 1 Clinical Isolates and Its Correlation with NS3 Sequence and Site-Directed MutantsThierry Verbinnen, Bart Fevery, Leen Vijgen, et al.Clinical Chemistry and Laboratory Medicine|June 29, 2010
Development and evaluation of an automated hepatitis C virus NS5B sequence-based subtyping assayDiana Koletzki, Stéphanie Dumont, Hans Vermeiren, et al.Antiviral Therapy|March 4, 2014
HCV RNA quantification with different assays: implications for protease-inhibitor-based response-guided therapyBart Fevery, Simone Susser, Oliver Lenz, et al.Journal of Hepatology|November 13, 2012
Virologic response and characterisation of HCV genotype 2-6 in patients receiving TMC435 monotherapy (study TMC435-C202)Oliver Lenz, Leen Vijgen, Jan Martin Berke, et al.Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|October 30, 2015
Comparison of three quantitative HCV RNA assays in samples from HCV genotype 1- or 4-infected patients treated with the NS3/4A protease inhibitor simeprevirBart Fevery, Simone Susser, Oliver Lenz, et al.Journal of Hepatology|December 3, 2014
Virology analyses of HCV isolates from genotype 1-infected patients treated with simeprevir plus peginterferon/ribavirin in Phase IIb/III studiesOliver Lenz, Thierry Verbinnen, Bart Fevery, et al.Virology Journal|January 31, 2018
A 3-year follow-up study after treatment with simeprevir in combination with pegylated interferon-α and ribavirin for chronic hepatitis C virus infectionFabien Zoulim, Christophe Moreno, Samuel S Lee, et al.Open Forum Infectious Diseases|May 18, 2016
Pre-existence and Persistence of Resistant Minority Hepatitis C Virus Variants in Genotype 1-Infected Patients Treated With Simeprevir/Peginterferon/RibavirinBart Fevery, Kim Thys, Veerle Van Eygen, et al.Antiviral Research|January 24, 2015
Prevalence of the hepatitis C virus NS3 polymorphism Q80K in genotype 1 patients in the European regionChristoph Sarrazin, Erkki Lathouwers, Monika Peeters, et al.Pageof 2